382 related articles for article (PubMed ID: 29514909)
1. HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.
Shi J; Xiong R; Zhou T; Su P; Zhang X; Qiu X; Li H; Li S; Yu C; Wang B; Ding C; Smithgall TE; Zheng YH
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514909
[TBL] [Abstract][Full Text] [Related]
2. Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.
Li S; Ahmad I; Shi J; Wang B; Yu C; Zhang L; Zheng YH
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355687
[TBL] [Abstract][Full Text] [Related]
3. Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity.
Staudt RP; Smithgall TE
J Biol Chem; 2020 Nov; 295(46):15540-15552. PubMed ID: 32873704
[TBL] [Abstract][Full Text] [Related]
4. An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.
Mumby MJ; Johnson AL; Trothen SM; Edgar CR; Gibson R; Stathopulos PB; Arts EJ; Dikeakos JD
J Virol; 2021 Jul; 95(16):e0058821. PubMed ID: 34037423
[TBL] [Abstract][Full Text] [Related]
5. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
[TBL] [Abstract][Full Text] [Related]
6. A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation.
Firrito C; Bertelli C; Rosa A; Chande A; Ananth S; van Dijk H; Fackler OT; Stoneham C; Singh R; Guatelli J; Pizzato M
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992361
[TBL] [Abstract][Full Text] [Related]
7. The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5.
Ahmad I; Li S; Li R; Chai Q; Zhang L; Wang B; Yu C; Zheng YH
J Biol Chem; 2019 Apr; 294(17):7013-7024. PubMed ID: 30862674
[TBL] [Abstract][Full Text] [Related]
8. Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.
Wu Y; Olety B; Weiss ER; Popova E; Yamanaka H; Göttlinger H
mBio; 2019 Jun; 10(3):. PubMed ID: 31186327
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Nef sequesters MHC-I intracellularly by targeting early stages of endocytosis and recycling.
Dirk BS; Pawlak EN; Johnson AL; Van Nynatten LR; Jacob RA; Heit B; Dikeakos JD
Sci Rep; 2016 Nov; 6():37021. PubMed ID: 27841315
[TBL] [Abstract][Full Text] [Related]
10. Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.
Zhang X; Zhou T; Yang J; Lin Y; Shi J; Zhang X; Frabutt DA; Zeng X; Li S; Venta PJ; Zheng YH
J Virol; 2017 May; 91(10):. PubMed ID: 28275190
[TBL] [Abstract][Full Text] [Related]
11. Two Functional Variants of AP-1 Complexes Composed of either γ2 or γ1 Subunits Are Independently Required for Major Histocompatibility Complex Class I Downregulation by HIV-1 Nef.
Tavares LA; de Carvalho JV; Costa CS; Silveira RM; de Carvalho AN; Donadi EA; daSilva LLP
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915283
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
Rosa A; Chande A; Ziglio S; De Sanctis V; Bertorelli R; Goh SL; McCauley SM; Nowosielska A; Antonarakis SE; Luban J; Santoni FA; Pizzato M
Nature; 2015 Oct; 526(7572):212-7. PubMed ID: 26416734
[TBL] [Abstract][Full Text] [Related]
13. The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
Trautz B; Wiedemann H; Lüchtenborg C; Pierini V; Kranich J; Glass B; Kräusslich HG; Brocker T; Pizzato M; Ruggieri A; Brügger B; Fackler OT
J Biol Chem; 2017 Aug; 292(33):13702-13713. PubMed ID: 28659343
[TBL] [Abstract][Full Text] [Related]
14. AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4.
Olety B; Usami Y; Wu Y; Peters P; Göttlinger H
mBio; 2023 Feb; 14(1):e0338222. PubMed ID: 36622146
[TBL] [Abstract][Full Text] [Related]
15. Two sorting motifs, a ubiquitination motif and a tyrosine motif, are involved in HIV-1 and simian immunodeficiency virus Nef-mediated receptor endocytosis.
Cai CY; Zhang X; Sinko PJ; Burakoff SJ; Jin YJ
J Immunol; 2011 May; 186(10):5807-14. PubMed ID: 21482738
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Nef interacts with the cyclin K/CDK13 complex to antagonize SERINC5 for optimal viral infectivity.
Chai Q; Li S; Collins MK; Li R; Ahmad I; Johnson SF; Frabutt DA; Yang Z; Shen X; Sun L; Hu J; Hultquist JF; Peterlin BM; Zheng YH
Cell Rep; 2021 Aug; 36(6):109514. PubMed ID: 34380030
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 restriction by SERINC5.
Cano-Ortiz L; Luedde T; Münk C
Med Microbiol Immunol; 2023 Apr; 212(2):133-140. PubMed ID: 35333966
[TBL] [Abstract][Full Text] [Related]
18. Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity.
Jin SW; Alsahafi N; Kuang XT; Swann SA; Toyoda M; Göttlinger H; Walker BD; Ueno T; Finzi A; Brumme ZL; Brockman MA
Cell Rep; 2019 Nov; 29(6):1449-1457.e5. PubMed ID: 31693887
[TBL] [Abstract][Full Text] [Related]
19. An N-Glycosylated Form of SERINC5 Is Specifically Incorporated into HIV-1 Virions.
Sharma S; Lewinski MK; Guatelli J
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158294
[TBL] [Abstract][Full Text] [Related]
20. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.
Swigut T; Iafrate AJ; Muench J; Kirchhoff F; Skowronski J
J Virol; 2000 Jun; 74(12):5691-701. PubMed ID: 10823877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
